The company fully deploys 2017 work
Release time:
2020-07-30
News from our newspaper 1# April 19 , the group company held a business analysis meeting to review and summarize the work situation in 2016 , arrange and deploy the work for the new year, and put forward the work requirements. At the
meeting, various professional companies and directly affiliated enterprises made a report on the overall work situation of 2016 , focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and a work plan for 2017 . Lan Xiaolong, the financial director of the group company, analyzes the risks and challenges currently faced by the company according to the operating data and financial situation of each subordinate enterprise. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resource efficiency and human resource development of the company, and hoped that the business management teams would use new thinking and new concepts to rationally allocate and effectively use human resources. Chen Tianci, assistant to the general manager of the group company, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2016 . Yu Jianhong, general manager of
Group Company, made a comprehensive review of the company's operation in 2016 , made a comparative analysis of the main economic indicators of various industrial sectors, and pointed out the highlights of "three reductions and three improvements", such as achieving actual results, breakthroughs in marketing work, and obvious effects of technological innovation and technological transformation, summarize and reflect on the deficiencies in strategic decision-making, management efficiency, product development and technological innovation capabilities, market operation capabilities, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong reported the benefit targets of various professional companies and directly affiliated enterprises for 2017 , and put forward ten key tasks: unifying ideological understanding and creating joint forces for enterprises; Actively grasp the development of various business sectors; Promote the construction of information management; Optimize the organizational structure and post setting; Improve management standards; Gradually try out the "amoeba" management concept; continue to deepen the work of "three reductions and three improvements"; do a good job in marketing management; focus on technological innovation, technological transformation and product development; safety and environmental protection management work to a new level. In his concluding speech, Jiang Xiaomeng, chairman of
Group Company, expressed his gratitude to all enterprises for their efforts and achievements in 2016 . He hoped that the management teams of all subordinate enterprises would fully understand the development and changes of the current economic situation, improve their ability to find and solve problems, take the lead in doing things, be strict with themselves, be able to learn, have ideas, lead teams and be respected, management team that will implement and produce benefits; Functional departments and offices should improve their work initiative and initiative, continue to learn, improve their ability to handle various affairs, and provide good service and guidance for subordinate enterprises. Jiang Xiaomeng hopes that cadres and employees at all levels will do a solid job in all kinds of work with extremely high execution and action ability in 2017 , and grow up with the peak while completing the annual tasks in an all-round way. (Reporter Fu Yiwu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page